(0.06%) 5 217.01 points
(0.21%) 39 469 points
(-0.14%) 16 323 points
(-0.15%) $79.14
(-0.35%) $2.29
(1.01%) $2 364.00
(0.18%) $28.42
(0.90%) $999.75
(0.16%) $0.929
(-0.12%) $10.85
(0.11%) $0.799
(0.03%) $92.57
@ $21.16
Issued: 14 Feb 2024 @ 15:35
Return: -15.83%
Previous signal: Feb 13 - 13:28
Previous signal:
Return: -2.49 %
Live Chart Being Loaded With Signals
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers...
Stats | |
---|---|
Today's Volume | 1 848.00 |
Average Volume | 178 925 |
Market Cap | 596.52M |
Next earnings date | ( $0 ) 2024-06-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.0770 (0.43%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-30 | Hillhouse Investment Management, Ltd. | Buy | 555 555 | Common Stock |
2024-01-30 | Hillhouse Investment Management, Ltd. | Buy | 313 076 | Common Stock |
2024-01-30 | Hillhouse Investment Management, Ltd. | Buy | 3 616 041 | Common Stock |
2024-01-30 | Hillhouse Investment Management, Ltd. | Sell | 4 761 903 | Series B Preferred Stock |
2024-01-30 | Hillhouse Investment Management, Ltd. | Sell | 55 000 000 | Series A Preferred Stock |
INSIDER POWER |
---|
-74.77 |
Last 24 transactions |
Buy: 9 226 636 | Sell: 63 909 387 |
Volume Correlation
ArriVent BioPharma, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
ArriVent BioPharma, Inc. Correlation - Currency/Commodity
Financial Reports:
No articles found.
ArriVent BioPharma, Inc.
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators